Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: A preliminary study

Ophthalmology

Volumn 107, Issue 6, 2000, Pages 1178-1183

  Aung, Tin ^a   Wong, Hon T ^a   Yip, Chee C ^a   Leong, Joy Y N ^c   Chan, Yiong Huak ^c   Chew, Paul T K ^b  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c Clinical Trials and Epidemiology Research Unit   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TIMOLOL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CONJUNCTIVA DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EROSION; DOUBLE BLIND PROCEDURE; FEMALE; GONIOSCOPY; HEADACHE; HUMAN; HYPEREMIA; INTRAOCULAR PRESSURE; IRIDOTOMY; MALE; MULTICENTER STUDY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG EVALUATION; FEMALE; GLAUCOMA, ANGLE-CLOSURE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; TIMOLOL; TREATMENT OUTCOME;

EID: 0033773106     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(00)00073-7     Document Type: Article

References (18)

1. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol
2. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group
3. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. The United States Latanoprost Study Group
4. A six month randomized double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group
5. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study
6. Latanoprost, a prostaglandin analog, for glaucoma treatment. Efficacy and safety after 1 year of treatment in 198 patients. The Latanoprost Study Groups
7. Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group
8. 2(α) analogue, on aqueous humor dynamics in human eyes
9. 2(α) analogue, after topical application in normal and ocular hypertensive human eyes
10. 2(α) analogue
11. Global data on blindness
12. Number of people with glaucoma worldwide
13. Glaucoma in Mongolia. A population based survey in Hovsgol Province, Northern Mongolia
14. Issues in the epidemiology and population based screening of primary angle-closure glaucoma
15. Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma
16. Effects on IOP restoration and blood-aqueous barrier after long term treatment with latanoprost in open angle glaucoma and ocular hypertension
17. Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability
18. The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humor protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%